Chemical safety assessment using read-across: Assessing the use of novel testing methods to strengthen the evidence base for decision making

Environmental Health Perspectives

Volumn 123, Issue 12, 2015, Pages 1232-1240

  Berggren, Elisabet ^a   Amcoff, Patric ^b   Benigni, Romualdo ^c   Blackburn, Karen ^d   Carney, Edward ^e   Cronin, Mark ^f   Deluyker, Hubert ^g   Gautier, Francoise ^h   Judson, Richard S ⁱ   Kass, Georges E N ^g   Keller, Detlef ^j   Knight, Derek ^k   Lilienblum, Werner ^l   Mahony, Catherine ^d   Rusyn, Ivan ^m   Schultz, Terry ⁿ   Schwarz, Michael ^o   Schüürmann, Gerrit ^p,q   White, Andrew ^r   Burton, Julien ^a   Lostia, Alfonso M ^a   Munn, Sharon ^a   Worth, Andrew ^a   more..

^a JOINT RESEARCH CENTRE   (Italy)

^b Cosmetics Europe ^*  (Belgium)

^c OECD   (France)

^d PROCTER AND GAMBLE COMPANY   (United States)

^e DOW CHEMICAL COMPANY   (United States)

^f LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^g EUROPEAN FOOD SAFETY AUTHORITY   (Italy)

^h L ORÉAL RECHERCHE   (France)

ⁱ U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^j HENKEL KGAA   (Germany)

^k EUROPEAN CHEMICALS AGENCY   (Finland)

^l SCCS (Scientific Committee on Consumer Safety)   (Luxembourg)

^m TEXAS A AND M UNIVERSITY   (United States)

ⁿ UNIVERSITY OF TENNESSEE   (United States)

^o UNIVERSITY OF TÜBINGEN   (Germany)

^p HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^q TU BERGAKADEMIE FREIBERG   (Germany)

^r UNILEVER RESEARCH   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TESTING ALTERNATIVE; CHEMICAL SAFETY; COMPUTER SIMULATION; DECISION MAKING; EUROPEAN UNION; HUMAN; PROCEDURES; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STANDARDS; TOXICITY TESTING;

ANIMAL TESTING ALTERNATIVES; CHEMICAL SAFETY; COMPUTER SIMULATION; DECISION MAKING; EUROPEAN UNION; HUMANS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; TOXICITY TESTS;

EID: 84948166805     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1409342     Document Type: Review

References (72)

1. Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, et al. 2010. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730-741.
2. Ball N, Bartels M, Budinsky R, Klapacz J, Hays S, Kirman C, et al. 2014. The challenge of using read-across within the EU REACH regulatory framework; how much uncertainty is too much? Dipropylene glycol methyl ether acetate, an exemplary case study. Regul Toxicol Pharmacol 68:212-221.
3. Berggren E. 2014. SEURAT-1 proof-of-concepts. In: Towards the Replacement of in Vivo Repeated Dose Systemic Toxicity Testing. Vol. 4 (Gocht T, Schwarz M, eds). Le Perreux-sur-Marne, France:Coach Consortium, 86-93. Available: http://www.seurat-1.eu/media/download_gallery/SEURAT-1_Annual%20Report_Vol%204_HD.pdf [accessed 24 September 2014].
4. Blackburn K, Bjerke D, Daston G, Felter S, Mahony C, Naciff J, et al. 2011. Case studies to test: a framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments. Regul Toxicol Pharmacol 60:120-135.
5. Blackburn K, Stuard SB. 2014. A framework to facilitate consistent characterization of read across uncertainty. Regul Toxicol Pharmacol 68:353-362.
6. Boobis AR, Doe JE, Heinrich-Hirsch B, Meek ME, Munn S, Ruchirawat M, et al. 2008. IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit Rev Toxicol 38:87-96.
7. Bradbury SP, Christensen GM. 1991. Inhibition of alcohol dehydrogenase activity by acetylenic and allylic alcohols: concordance with in vivo electrophilic reactivity in fish. Environ Toxicol Chem 10:1155-1160.
8. Cosmetics Europe. 2015. Cosmetics Europe, the Personal Care Association Homepage. Available: https://www.cosmeticseurope.eu/[accessed 15 April 2015].
9. COSMOS (Cosmetics to Optimise Safety). 2011. The SEURAT-1 Project COSMOS Homepage. Available: http://www.cosmostox.eu/home/welcome/[accessed 15 April 2015].
10. COSMOS. 2014. The COSMOS Database on Chemical and Toxicological Data for Cosmetics Ingredients. Available: http://cosmosdb.cosmostox.eu/[accessed 15 April 2015].
11. Cronin MTD, Madden JC, Enoch SJ, Roberts DW. 2013. Chemical Toxicity Prediction: Category Formation and Read-Across. London, UK:The Royal Society of Chemistry.
12. Davis CD, Hanumegowda UM. 2009. The role of drug metabolism in toxicology. In: Drug Metabolism Handbook: Concepts and Applications (Nassar AF, Hollenberg PF, Scatina J, eds). Hoboken, NJ:John Wiley & Sons, 561-628.
13. Doi AM, Hill G, Seely J, Hailey JR, Kissling G, Bucher JR. 2007. a2u-Globulin nephropathy and renal tumors in national toxicology program studies. Toxicol Pathol 35:533-540.
14. EC (European Commission). 2004. Trichloroethylene. CAS No: 79-01-6. EINECS No: 201-167-4. Summary Risk Assessment Report. Available: http://echa.europa.eu/documents/10162/d30e53cc-89e7-4d1c-89c0-7ec216f84d48 [accessed 15 April 2015].
15. EC. 2005. Tetrachloroethylene: Part I - Environment. CAS No: 127-18-4. EINECS No: 204-825-9. Summary Risk Assessment Report. Available: http://echa.europa.eu/documents/10162/733515ca-7d61-463c-9cde-af560097ce25 [accessed 15 April 2015].
16. EC. 2007. Research and Innovation: FP7 Homepage. Available: http://ec.europa.eu/research/fp7/[accessed 15 April 2015].
17. EC. 2013. Scientific Committee on Consumer Safety (SCCS) Homepage. Available: http://ec.europa.eu/health/scientific_committees/consumer_safety/ [accessed 15 April 2015].
18. ECHA (European Chemicals Agency). 2008. Guidance on Information Requirements and Chemical Safety Assessment. Chapter R.6: QSARs and Grouping of Chemicals. Available: http://echa.europa.eu/documents/10162/13632/information_requirements_r6_en.pdf [accessed 15 April 2015].
19. ECHA. 2012. Practical Guide 6. How to Report Read-Across and Categories. ECHA-10-B-11.1-EN. Available: http://echa.europa.eu/documents/10162/13655/pg_report_readacross_en.pdf [accessed 15 April 2015].
20. ECHA. 2013a. Grouping of Substances and Read-Across Approach. Part 1: Introductory Note. ECHA-13-R-02-EN. Available: http://echa.europa.eu/documents/10162/13628/read_across_introductory_note_en.pdf [accessed 15 April 2015].
21. ECHA. 2013b. Read-Across Illustrative Example. Part 2: Example 1 - Analogue Approach: Similarity Based on Breakdown Products. ECHA-13-R-03-EN. Available: http://echa.europa.eu/documents/10162/13628/read_across_example_1_en.pdf [accessed 15 April 2015].
22. ECHA. 2014. The Use of Alternatives to Testing on Animals for the REACH Regulation. Second Report under Article 117(3) of the REACH Regulation. ECHA-14-A-07-EN. Available: http://echa.europa.eu/documents/10162/13639/alternatives_test_animals_2014_en.pdf [accessed 15 April 2015].
23. EFSA (European Food Safety Authority). 2015. European Food Safety Authority Homepage. Available: http://www.efsa.europa.eu/[accessed 15 April 2015].
24. EU (European Union). 2006. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). Available: http://eur-lex.europa.eu/legal-content/EN/TXT/?qid = 1428942204927&uri=CELEX:32006R1907 [accessed 15 April 2015].
25. EU. 2009. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on Cosmetic Products. Available: http://eur-lex.europa.eu/legal-content/EN/TXT/?qid = 1428942330235&uri=CELEX:32009R1223 [accessed 15 April 2015].
26. EU. 2010. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the Protection of Animals Used for Scientific Purposes. Available: http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1428942397721&uri=CELEX:32010L0063 [accessed 15 April 2015].
27. Fukuto TR. 1990. Mechanism of action of organo-phosphorus and carbamate insecticides. Environ Health Perspect 87:245-254.
28. HeMiBio (Hepatic Microfluidic Bioreactor). 2011. The SEURAT-1 Project HeMiBio Homepage. Available: http://www.hemibio.eu/[accessed 15 April 2015].
29. Johnson AM, Maggiora GM. 1990. Concepts and applications of Molecular Similarity. New York:John Wiley & Sons.
30. Kleinstreuer NC, Yang J, Berg EL, Knudsen TB, Richard AM, Martin MT, et al. 2014. Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms. Nat Biotechnol 32:583-591.
31. Krewski D, Acosta D Jr, Andersen M, Anderson H, Bailar JC III, Boekelheide K, et al. 2010. Toxicity testing in the 21st century: a vision and a strategy. J Toxicol Environ Health B Crit Rev 13:51-138.
32. Landesmann B, Goumenou M, Munn S, Whelan M. 2012. Description of Prototype Modes-of-Action Related to Repeated Dose Toxicity. European Commission, Joint Research Centre, JRC Scientific and Policy Report 75689. Available: http://publications.jrc.ec.europa.eu/repository/handle/JRC75689 [accessed 15 April 2015].
33. Landesmann B, Vinken M. 2013. Mode-of-Action Working Group: capturing mode-of-action knowledge. In: Towards the Replacement of in Vivo Repeated Dose Systemic Toxicity Testing. Vol. 3 (Gocht T, Schwarz M, eds). Le Perreux-sur-Marne, France:Coach Consortium, 283-321. Available: http://www.seurat-1.eu/media/download_gallery/SEURAT%201-v3.pdf[accessed 15 April 2015].
34. Lockley DJ, Howes D, Williams FM. 2005. Cutaneous metabolism of glycol ethers. Arch Toxicol 79:160-168.
35. Lostia A. 2014. Mode-of-action-based classification model for repeated dose liver toxicity. In: Towards the Replacement of in Vivo Repeated Dose Systemic Toxicity Testing. Vol. 4 (Gocht T, Schwarz M, eds). Le Perreux-sur-Marne, France:Coach Consortium, 104-106. Available: http://www.seurat-1.eu/media/download_gallery/SEURAT-1_Annual%20Report_Vol%204_HD.pdf [accessed 15 April 2015].
36. Low Y, Sedykh A, Fourches D, Golbraikh A, Whelan M, Rusyn I, et al. 2013. Integrative chemical-biological read-across approach for chemical hazard classification. Chem Res Toxicol 26:1199-1208.
37. National Research Council. 2007. Toxicity Testing in the 21st Century: a Vision and a Strategy. Washington, DC:National Academies Press. Available: http://www.nap.edu/openbook.php?record_id=11970 [accessed 15 April 2015].
38. Nelson JW, Hatch EE, Webster TF. 2010. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ Health Perspect 118:197-202; doi:10.1289/ehp.0901165.
39. Noor F, Heinzle E. 2014. Evaluation of valproic acid induced steatosis in HepaRG cells. In: Towards the Replacement of in Vivo Repeated Dose Systemic Toxicity Testing. Vol. 4 (Gocht T, Schwarz M, eds). Le Perreux-sur-Marne, France:Coach Consortium, 98-99. Available: http://www.seurat-1.eu/media/download_gallery/SEURAT-1_Annual%20Report_Vol%204_HD.pdf [accessed 15 April 2015].
40. OECD (Organisation for Economic Co-operation and Development). 2013a. Guidance Document on Developing and Assessing Adverse Outcome Pathways. ENV/JM/MONO(2013)6. Available: http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote = env/jm/mono%282013%296&doclanguage=en [accessed 15 April 2015].
41. OECD. 2013b. QSAR Toolbox Homepage. The OECD QSAR Toolbox for Grouping Chemicals into Categories. Available: http://www.qsartoolbox.org/home[accessed 15 April 2015].
42. OECD. 2014a. Guidance on Grouping of Chemicals, Second Edition. ENV/JM/MONO(2014)4. Available: http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote = env/jm/mono%282014%294&doclanguage=en [accessed 15 April 2015].
43. OECD. 2014b. The Adverse Outcome Pathway Knowledge Base (AOP-KB): AOP-Wiki. Available: https://aopkb.org [accessed 15 April 2015].
44. O’Shea SH, Schwarz J, Kosyk O, Ross PK, Ha MJ, Wright FA, et al. 2011. In vitro screening for population variability in chemical toxicity. Toxicol Sci 119:398-407.
45. Reif DM, Martin MT, Tan S, Houck KA, Judson R, Richard AM, et al. 2010. Endocrine profiling and prioritization of environmental chemicals using ToxCast data. Environ Health Perspect 118:1714-1720; doi:10.1289/ehp.1002180.
46. Reif DM, Sypa M, Lock EF, Wright FA, Wilson A, Cathey T, et al. 2013. ToxPi GUI: an interactive visualization tool for transparent integration of data from diverse sources of evidence. Bioinformatics 29:402-403.
47. RIFM (Research Institute for Fragrance Materials). 2014. The RIFM Database. Available: http://www.rifm.org/rifm-science-database.php[accessed 15 April 2015].
48. Rogers DJ, Tanimoto TT. 1960. A computer program for classifying plants. Science 132:1115-1118.
49. Rusyn I, Corton JC. 2012. Mechanistic considerations for human relevance of cancer hazard of di(2-ethylhexyl) phthalate. Mutat Res 750:141-158.
50. Schultz TW, Amcoff P, Berggren E, Gautier F, Klaric, Knight DJ, et al. 2015. A strategy for structuring and reporting a read-across prediction of toxicity. Regul Toxicol Pharmacol 72:586-601.
51. SEURAT-1 (Safety Evaluation Ultimately Replacing Animal Testing, Step 1). 2011. SEURAT-1 Homepage. Available: http://www.seurat-1.eu/[accessed 15 April 2015].
52. Strubelt O, Deters M, Pentz R, Siegers CP, Younes M. 1999. The toxic and metabolic effects of 23 aliphatic alcohols in the isolated perfused rat liver. Toxicol Sci 49:133-142.
53. Sturla SJ, Boobis AR, FitzGerald RE, Hoeng J, Kavlock KJ, Schirmer K, et al. 2014. Systems toxicology: from basic research to risk assessment. Chem Res Toxicol 27:314-329.
54. Todeschini R, Consonni V. 2009. Molecular Descriptors for Chemoinformatics. 2nd ed. Weinheim, Germany:Wiley-VCH Verlag GmbH & Co.
55. ToxBank. 2014. Gold Compounds Wiki Pages. Available: http://www.toxbank.net/compound-wiki[accessed 15 April 2015].
56. U.S. ATSDR (U.S. Agency for Toxic Substances and Disease Registry). 2002. Toxicological Profile for Di(2-ethylhexyl)phthalate (DEHP). Available: http://www.atsdr.cdc.gov/ToxProfiles/tp.asp?id=684&tid=65 [accessed 15 April 2015].
57. U.S. ATSDR. 2014a. Toxicological Profile for Tetrachloroethylene (PERK). Draft for Public Comment. Available: http://www.atsdr.cdc.gov/ToxProfiles/tp.asp?id=265&tid=48 [accessed 15 April 2015].
58. U.S. ATSDR. 2014b. Toxicological Profile for Trichloroethylene (TCE). Draft for Public Comment. Available: http://www.atsdr.cdc.gov/ToxProfiles/tp.asp?id=173&tid=30 [accessed 15 April 2015].
59. U.S. EPA (U.S. Environmental Protection Agency). 2010. ToxRefDB [Toxicity Reference Database]. Available: http://actor.epa.gov/toxrefdb[accessed 15 April 2015].
60. U.S. EPA. 2014. ToxCast™ Data. Available: http://www.epa.gov/ncct/toxcast/data.html [accessed 15 April 2015].
61. van Leeuwen K, Schultz TW, Henry T, Diderich R, Veith GD. 2009. Using chemical categories to fill data gaps in hazard assessment. SAR QSAR Environ Res 20:207-220.
62. Wambaugh JF, Setzer RW, Pitruzzello AM, Liu J, Reif DM, Kleinstreuer NC, et al. 2013. Dosimetric anchoring of in vivo and in vitro studies for perfluo-rooctanoate and perfluorooctanesulfonate. Toxicol Sci 136:308-327.
63. Wess AJ. 1992. Reproductive toxicity of ethylene glycol monomethyl ether, ethylene glycol monoethyl and their acetates. Scand J Work Environ Health 18(suppl 2):43–45.
64. Wetmore BA, Wambaugh JF, Ferguson SS, Sochaski MA, Rotroff DM, Freeman K, et al. 2012. Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment. Toxicol Sci 125:157-174.
65. Whelan M, Schwarz M, Scientific Expert Panel of the SEURAT-1 Research Initiative. 2011. SEURAT: vision, research strategy and execution. In: Towards the Replacement of in Vivo Repeated Dose Systemic Toxicity Testing. Vol. 1 (Gocht T, Schwarz M, eds). Le Perreux-sur-Marne, France:Coach Consortium, 47-52. Available: http://www.seurat-1.eu/media/download_gallery/SEURAT-1_Annual%20Report_Vol%201_Sept2011_HR.pdf [accessed 15 April 2015].
66. Whelan M, Schwarz M, Scientific Expert Panel of the SEURAT-1 Research Initiative. 2012. Elaborating the SEURAT-1 research strategy. In: Towards the Replacement of in Vivo Repeated Dose Systemic Toxicity Testing. Vol. 2 (Gocht T, Schwarz M, eds). Le Perreux-sur-Marne, France:Coach Consortium, 47-63. Available: http://www.seurat-1.eu/media/download_gallery/SEURAT%201v2HD.pdf [accessed 15 April 2015].
67. Whelan M, Schwarz M, Scientific Expert Panel of the SEURAT-1 Research Initiative. 2013. The SEURAT-1 research strategy: proving concepts. In: Towards the Replacement of in Vivo Repeated Dose Systemic Toxicity Testing. Vol. 3 (Gocht T, Schwarz M, eds). Le Perreux-sur-Marne, France:Coach Consortium, 57-72. Available: http://www.seurat-1.eu/media/download_gallery/SEURAT%201-v3.pdf[accessed 15 April 2015].
68. White A, Knight D. 2014. Safety Assessment Working Group. In: Towards the Replacement of in Vivo Repeated Dose Systemic Toxicity Testing. Vol. 4 (Gocht T, Schwarz M, eds). Le Perreux-sur-Marne, France:Coach Consortium, 327-331. Available: http://www.seurat-1.eu/media/download_gallery/SEURAT-1_Annual%20Report_Vol%204_HD.pdf [accessed 15 April 2015].
69. Wilkening S, Stahl F, Bader A. 2003. Comparison of primary human hepatocytes and hepatoma cell line HepG2 with regard to their biotransformation properties. Drug Metab Dispos 31:1035-1042.
70. Wiseman J. 2012. Mechanism-based selection of reference compounds for toxicity testing procedures. In: Towards the Replacement of in Vivo Repeated Dose Systemic Toxicity Testing. Vol. 2 (Gocht T, Schwarz M, eds). Le Perreux-sur-Marne, France:Coach Consortium, 278-281. Available: http://www.seurat-1.eu/media/download_gallery/SEURAT%201v2HD.pdf [accessed 15 April 2015].
71. Wu S, Blackburn K, Amburgey J, Jaworska J, Federle T. 2010. A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments. Regul Toxicol Pharmacol 56:67-81.
72. Zhang L, Ren XM, Guo LH. 2013. Structure-based investigation on the interaction of perfluorinated compounds with human liver fatty acid binding protein. Environ Sci Technol 47:11293-11301.